News

Medical Data Vision Co., Ltd. (MDV, listed on the Tokyo Stock Exchange Prime Market, 3902; Head Office: Chiyoda-ku, Tokyo; President & CEO: Hiroyuki Iwasaki) and TXP Medical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo; CEO & MD: Tomohiro Sono) will co-host a seminar on real-world data (RWD) at Pharma Innovation EXPO 2025, organized by Mediwill Co., Ltd., on Wednesday, November 26, 2025.

Those interested in attending the seminar can register via the following URL:
https://www.mediwill.co.jp/seminar/pharma_innovation_expo_2025

In addition, MDV and TXP Medical will jointly host an online booth from October 1 to November 26. We warmly welcome your participation.

---

Event Details

• Date & Time: Wednesday, November 26, 2025, 13:15 – 13:45 JST
  
• Theme: The Future of RWD Shaped by MDV × TXP Medical – New Initiatives in Regimen Structuring Programs
  
• Speakers:
  
  1. Junichiro Shibata, MD, Clinical Data Science Lead, Medical Data Division, TXP Medical
     
  2. Hiroyuki Tada, Senior Manager, EBM Promotion Department, EBM Headquarters, MDV
     
• Target Audience: Professionals from pharmaceutical companies, medical device manufacturers, and healthcare-related organizations
  
• Format: Webinar via Zoom Event
  
• Fee: Free

---

Seminar Overview

MDV provides comprehensive real-world evidence (RWE) using a database of over 50 million patient records collected from hospitals nationwide, including DPC, claims, and lab test data. TXP Medical, on the other hand, focuses on core institutions such as university hospitals, enabling high-precision analysis in acute and rare disease areas using structured medical chart texts and standardized test values.

This seminar will showcase concrete examples of how combining the strengths of both companies can support new drug development, clinical research, and the improvement of healthcare quality.

---

For Inquiries:

 EBM Promotion Department, Medical Data Vision Co., Ltd.
Email: ebm_sales@mdv.co.jp